| Literature DB >> 35407482 |
Ghizlene Lahlou1,2, Hannah Daoudi1,2, Evelyne Ferrary1,2, Huan Jia3, Marion De Bergh1, Yann Nguyen1,2, Olivier Sterkers1,2, Isabelle Mosnier1,2.
Abstract
Cochlear implantation is usually not recommended for prelingual profoundly deaf adults, although some of these patients might benefit from it. This study aims to define the candidates for cochlear implantation in this population. This retrospective study reviewed 34 prelingual profoundly deaf patients who had received a cochlear implant at 32 ± 1.7 years old (16-55), with at least 1 year of follow-up. Speech perception and quality of life were assessed before and 3, 6, and 12 months after cochlear implantation, then every year thereafter. According to the word speech intelligibility in quiet (WSI) 1 year after implantation, two groups were identified: good performer (GP) with WSI ≥ 50% (n = 15), and poor performer (PP) with WSI ≤ 40% (n = 19). At the 1 year mark, mean WSI improved by 28 ± 4.6% (-20-100) (p < 0.0001). In GP, the intelligibility for words and sentences, communication and quality of life scales improved. In PP, the communication scale improved, but not auditory performance or quality of life. GP and PP differed pre-operatively in speech production, communication abilities, and WSI in best-aided conditions. In prelingual profoundly deaf adults, a dramatic auditory performance benefit could be expected after cochlear implantation if the patients have some degree of speech intelligibility in aided conditions and have developed oral communication and speech production.Entities:
Keywords: cochlear implant; prelingual profound hearing loss; quality of life; speech perception
Year: 2022 PMID: 35407482 PMCID: PMC8999851 DOI: 10.3390/jcm11071874
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of patient inclusion.
Characteristics of implanted patients classified in function of speech intelligibility of disyllabic word score in quiet (WSI) with one cochlear implant 1 year after implantation (best or first implant outcomes are given for simultaneous or sequential bilateral implantation, respectively). Good and poor performers are patients 1 to 15 and 16 to 34, respectively.
| Patient | Sex | HL Etiology | HL Class at dg ¥ | Age at dg (Months) | Age at First HA (Months) | Duration without HA (Years) | Social Category | CAP | SIR | Communication † | Preoperative PTA (dB) | Type of Implantation | Age at CI (Years) | Year of First CI | CI Model | WSI at One Year (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CI Ear | Non-CI Ear | CI Ear | Non-CI Ear | |||||||||||||||
| 1 | F | Unknown | S | 12 | 12 | 12 | 1 | 7 | 5 | 5 | O | 115 | 114 | Unilateral | 29 | 2019 | CI522 | 100 |
| 2 | F | Unknown | P | 24 | 24 | 24 | 2 | 7 | 7 | 5 | O | 102.5 | 99 | Bilateral seq. | 22 | 2010 | Ci512 | 90 |
| 3 | M | Cnx 26 | P | 24 | 24 | 24 | 2 | 7 | NR | 5 | O | 120 | 111 | Bilateral seq. | 26 | 2015 | CI24RE | 80 |
| 4 | F | Unknown | S | 24 | 24 | 24 | 2 | 7 | 5 | 5 | O | 99 | 98 | Unilateral | 39 | 2014 | CI24RE | 70 |
| 5 | F | Cnx 26 | P | 12 | 12 | 12 | 1 | 6 | 6 | 5 | O | 99 | 99 | Unilateral | 16 | 2013 | CI24RE | 70 |
| 6 | M | Cnx 26 | S | 12 | 60 | 60 | 5 | 4 | 5 | 4 | O | 115 | 104 | Unilateral | 52 | 2018 | CI522 | 70 |
| 7 | F | IUI | P | 1 | 3 | 3 | 0 | 7 | 4 | 5 | O | 115 | 102.5 | Bilateral seq. | 45 | 2013 | Ci522 | 70 |
| 8 | F | Unknown | S | 24 | 24 | 24 | 2 | 6 | 5 | 5 | O | 109 | 99 | Bilateral seq. | 30 | 2012 | Med-El Flex31 | 60 |
| 9 | M | Meningitis | S | 3 | 96 | 144 | 8 | 1 | 5 | 4 | O | 105 | 105 | Bilateral sim. | 47 | 2018 | Neuro ZTI Evo | 60 |
| 10 | F | Cnx 26 | P | 16 | 16 | 16 | 1 | 7 | 6 | 5 | O | 102 | 96 | Unilateral | 32 | 2012 | CI24RE | 50 |
| 11 | F | Genetic | S | 40 | 40 | 40 | 3 | 7 | 5 | 4 | O + S | 109 | 112 | Bilateral seq. | 27 | 2012 | CI422 | 50 |
| 12 | F | IUI | P | 9 | 9 | 9 | 5 | 2 | 2 | 2 | O + S | 117 | 111 | Bilateral sim. | 20 | 2007 | Med-El | 50 |
| 13 | M | Cnx 26 | S | 15 | 16 | 16 | 1 | 7 | 5 | 4 | O | 111 | 109 | Unilateral | 32 | 2018 | CI522 | 50 |
| 14 | F | Unknown | P | 24 | 24 | 24 | 2 | 7 | 5 | 5 | O | 109 | 99 | Unilateral | 27 | 2018 | Ci522 | 50 |
| 15 | M | Unknown | S | 18 | 18 | 18 | 1.5 | 7 | 3 | 5 | O | 97.5 | 95 | Unilateral | 20 | 2013 | Ci422 | 50 |
| 16 | M | Unknown | S | 9 | 9 | 9 | 1 | 7 | 3 | 5 | O | 111 | 99 | Unilateral | 31 | 2013 | Ci422 | 40 |
| 17 | F | Cnx 26 | S | 6 | 6 | 6 | 0 | 7 | 5 | 5 | O | 116 | 108 | Bilateral sim. | 39 | 2016 | Ci512 | 40 |
| 18 | F | Cnx 26 | P | 45 | 167 | 45 | 14 | 7 | NR | NR | O + S | 114 | 115 | Unilateral | 45 | 2004 | Ci24CA | 30 |
| 19 | M | Unknown | P | 18 | 18 | 18 | 1 | 6 | 5 | 4 | O | 99 | 91 | Unilateral | 21 | 2012 | Ci24RE | 30 |
| 20 | F | Cnx 26 | P | 9 | 9 | 9 | 1 | 7 | 5 | 3 | O + S | 112 | 108 | Bilateral seq. | 25 | 2012 | Ci24RE | 30 |
| 21 | M | Cnx 26 | P | 12 | 12 | 12 | 6 | 6 | NR | NR | O + S | 110 | 106 | Unilateral | 33 | 2007 | Digisonic SP | 20 |
| 22 | M | Unknown | S | 36 | 36 | 36 | 3 | 6 | 5 | 3 | O + S | 115 | 116 | Unilateral | 32 | 2008 | CI24RE | 20 |
| 23 | F | Unknown | P | 3 | 3 | 3 | 0 | 7 | 4 | 2 | O + S | 110 | 104 | Unilateral | 18 | 2011 | CI24RE | 20 |
| 24 | F | Cnx 26 | P | 12 | 12 | 12 | 1 | 6 | 5 | 4 | O + S | 110 | 105 | Bilateral seq. | 30 | 2015 | Ci422 | 10 |
| 25 | M | Genetic | S | 36 | 36 | 36 | 3 | 6 | 5 | 4 | O + S | 99 | 115 | Unilateral | 21 | 2014 | Digisonic SP | 10 |
| 26 | F | Cnx 26 | P | 24 | 24 | 24 | 2 | 7 | 3 | 4 | O + S | 110 | 107 | Unilateral | 24 | 2016 | Ci422 | 10 |
| 27 | M | Genetic | S | 46 | 46 | 46 | 4 | 6 | 5 | 5 | O | 115 | 110 | Bilateral seq. | 41 | 2010 | Ci24RE | 0 |
| 28 | M | Premature | S | 24 | 29 | 29 | 2 | 3 | 3 | 3 | O + C | 99 | 94 | Unilateral | 33 | 2011 | Med-El Ti100 | 0 |
| 29 | F | Genetic | P | 18 | 71 | 71 | 36 | 6 | 4 | 4 | O | 109 | 110 | Bilateral sim. | 43 | 2008 | Ci24RE | 0 |
| 30 | F | IUI | P | 46 | - | - | 30 | 1 | 1 | 1 | C | 111 | 100 | Bilateral sim. | 30 | 2013 | Digisonic SP | 0 |
| 31 | F | Unknown | P | 36 | 36 | 36 | 10 | 4 | 1 | 1 | S | 120 | 120 | Bilateral sim. | 23 | 2013 | Digisonic SP | 0 |
| 32 | F | Cnx 26 | S | 12 | 12 | 12 | 1 | 7 | 5 | 4 | O | 110 | 112 | Bilateral sim. | 41 | 2015 | Ci422 | 0 |
| 33 | M | Genetic | P | 36 | NR | NR | NR | 4 | 3 | 2 | O + S | 116 | 120 | Unilateral | 24 | 2019 | NeuroZTI Evo | 0 |
| 34 | F | IUI | P | 36 | 120 | 36 | 10 | 4 | 2 | 3 | O | 112 | 111 | Bilateral seq. | 55 | 2013 | Digisonic Evo | 0 |
HL: Hearing loss; Cnx: connexin; IUI: intra-uterine infection; dg: diagnosis; HA: hearing aid; CI: cochlear implant; CAP: Category of Auditory Performance; SIR: Speech Intelligibility Rating; PTA (dB): pure tone audiometry (decibel); Bilateral seq: sequential; Bilateral sim: simultaneous; WSI: speech intelligibility for disyllabic words in quiet; NR: not-reported. ¥: S is for severe and P for profound; †: O is for oral, S for sign, C for code. The grey color is for good performers group.
Figure 2Post-operative evolution after cochlear implantation. (A) Speech intelligibility without lipreading for disyllabic words in silence in the 2 groups. Compared to the preoperative scores, an improvement was observed for the good performer group at 3 months (p = 0.015), 6 months (p = 0.0002), 1 year (p < 0.0001), and 2 years (p = 0.0005) post-implantation. For the poor performer group, no significant improvement was found. n = 15, 11, 11, 15, 8 for the good performer group, and 19, 10, 10, 19, 11 for the poor performer group, respectively at 0, 3, 6, 12, and 24 months after cochlear implantation. (B) Evolution of speech intelligibility for disyllabic words over time in the 2 groups. (n) are the number of patients at each time point. (C) Speech intelligibility without lipreading for MBAA sentences in the 2 groups. Compared to the preoperative scores, an improvement was observed for the good performer group at 6 months (p = 0.024), 1 year (p = 0.0007), and 2 years (p = 0.011) post-implantation. For the poor performer group, no significant improvement was found. n = 12, 11, 10, 14, 7 for the good performer group, and 9, 7, 8, 13, 10 for the poor performer group, respectively at 0, 3, 6, 12, and 24 months after cochlear implantation. (D) Mean ± SEM of APHAB scores before, 1 and 2 years after implantation in the 2 groups, showing an improvement only for the good performer group (p < 0.0001). APHAB, Abbreviated Profile of Hearing Aid Benefit. Data are mean ± SEM; a two-way ANOVA with a Tukey multiple comparisons test was performed for statistical analysis. * p < 0.05; *** p < 0.0005, **** p < 0.0001, ns: non significant.
Auditory performance in quiet with cochlear implant alone (best or first implanted ear for bilateral simultaneous or sequential implantation, respectively) and communication performance before and 1 year post-implantation in the two groups.
| Poor Performers | Good Performers | |||||
|---|---|---|---|---|---|---|
| Preoperative | 1 Year Post-CI | Preoperative | 1 Year Post-CI | |||
| Speech intelligibility | ||||||
| Disyllabic words | 4 ± 1.9 (0–30), | 14 ± 3.4 (0–40), | 0.052 ¥ | 11 ± 4.6 (0–50), | 65 ± 4.1 (50–100), | <0.0001 ¥ |
| Words in sentences | 2 ± 1.6 (0–14), | 30 ± 8.6 (0–77), | 0.13 ¥ | 20 ± 8.9 (0–92), | 75 ± 6.7 (30–100), | 0.001 ¥ |
| Sentences | 0 ± 0 (0–0), | 15 ± 6.2 (0–60), | 0.25 ¥ | 13 ± 7 (0–80), | 64 ± 5.2 (33–100), | 0.0007 ¥ |
| CAP | ||||||
| 1 | 2 | 0 | 0.015 ∞ | 0 | 0 | 0.0003 ∞ |
| 2 | 1 | 1 | 1 | 0 | ||
| 3 | 4 | 0 | 1 | 0 | ||
| 4 | 2 | 6 | 1 | 0 | ||
| 5 | 8 | 4 | 8 | 2 | ||
| 6 | 0 | 3 | 2 | 3 | ||
| 7 | 0 | 2 | 1 | 2 | ||
| 8 | 0 | 1 | 0 | 3 | ||
| 9 | 0 | 0 | 0 | 4 | ||
Good and poor performers had a speech intelligibility for disyllabic words in quiet ≥ and <50% at 1 year, respectively. CAP: Communication Auditory Performance; CI: cochlear implant. Data are given as mean ± SEM in % (range), and n for the intelligibility scores, and n for the CAP scores. ¥: two-way ANOVA; ∞: chi-squared test.
Figure 3Preoperative assessments in the 2 groups. (A) Preoperative speech intelligibility for disyllabic words evaluated in optimal listening condition (i.e., with the 2 hearing aids if used) without and with lip-reading. Good performer group (GP) obtained better scores compared with to the poor performer group (PP) for the speech intelligibility without and with lip-reading (respectively p = 0.022, n = 15 for GP and 18 for PP, and p = 0.012, n = 13 for GP and 18 for PP, Mann–Whitney test). (B) Preoperative Speech Intelligibility Rating (SIR) scores. GP (n = 15) had better scores compared with PP (n = 16) (p = 0.003, chi-squared test, 3 missing values in PP). (C) Preoperative Category of Auditory Performance (CAP) scores. GP (n = 14) had better scores compared with PP (n = 17) (p = 0.032, chi-squared test, 1 missing for GP and 2 for PP). Data are mean ± SEM (A) and n (B,C). * p < 0.05; ** p < 0.005.
Evolution in good and poor performers groups before and 1 year after the second implantation in bilateral sequential implantation patients (n = 9). Good (n = 5) and poor (n = 4) performers had a speech intelligibility for disyllabic words in quiet ≥ and <50% at 1 year after the first implantation, respectively (see Table 1).
| Poor Performers ( | Good Performers ( | |||||
|---|---|---|---|---|---|---|
| Before the 2nd | 1 Year Post-2nd | Before the 2nd | 1 Year Post-2nd | |||
| SI in quiet | ||||||
| Disyllabic words | 33 ± 16.5 (10–70), | 50 ± 13.5 (30–90), | 0.4 ¥ | 82 ± 11.1 (50–100), | 88 ± 6.3 (70–100), | 0.9 ¥ |
| Words in sentences | 48 ± 21.2 (0–94), | 66 ± 13.0 (44–89), | 0.9 ¥ | 83 ± 9.3 (51–100), | 89 ± 10.5 (68–100), | 0.7 ¥ |
| Sentences | 33 ± 17.7 (0–80), | 49 ± 17.4 (20–80), | 0.8 ¥ | 69 ± 13.6 (33–100), | 80 ± 16.6 (47–100), | 0.5 ¥ |
| SI in noise | ||||||
| Words in sentences | 25 ± 18.4 (0–78), | 38 ± 14.4 (11–60), | 0.9 ¥ | 55 ± 18.6 (3–91), | 78 ± 11.7 (56–100), | 0.1 ¥ |
| Sentences | 15 ± 15.0 (0–60), | 20 ± 7.5 (7–33), | 0.9 ¥ | 41 ± 17.4 (0–80), | 62 ± 20.1 (27–100), | 0.07 ¥ |
| APHAB | 45 ± 4.8 (33–57), | 45 ± 4.7 (37–57), | >0.9 ‡ | 48 ± 7.1 (33–67), | 39 ± 8.6 (15–57), | 0.6 ‡ |
| CAP | ||||||
| 5 | 1 | 1 | 0.8 ∞ | 1 | 0 | 0.09 ∞ |
| 6 | 0 | 0 | 1 | 0 | ||
| 7 | 0 | 1 | 1 | 0 | ||
| 8 | 2 | 1 | 1 | 2 | ||
| 9 | 1 | 1 | 1 | 2 | ||
SI: Speech intelligibility; CAP: Communication Auditory Performance. Data are mean ± SEM (range) in % for the intelligibility scores and the APHAB score, and n for the CAP score. ¥: two-way ANOVA; ∞: chi-squared test; ‡: Wilcoxon test.
Figure 4Decision algorithm for cochlear implantation in the case of an adult patient with prelingual severe-to-profound hearing loss. HA: hearing aid; SIR: Speech Intelligibility Response; CAP: Communication Auditory Performance.